This work is supported by grants awarded by the National Institutes of Health (GM066137, GM079359 and CA133086), by the National Key Scientific Program of China (2011CB911000), the China National Instrumentation Program (2011YQ03012412), and the Foundation for Innovative Research Groups of NSFC (21221003).
Communication
DNA Aptamer-Mediated Cell Targeting†
Article first published online: 11 DEC 2012
DOI: 10.1002/anie.201207063
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Xiong, X., Liu, H., Zhao, Z., Altman, M. B., Lopez-Colon, D., Yang, C. J., Chang, L.-J., Liu, C. and Tan, W. (2013), DNA Aptamer-Mediated Cell Targeting . Angew. Chem. Int. Ed., 52: 1472–1476. doi: 10.1002/anie.201207063
- †
Publication History
- Issue published online: 23 JAN 2013
- Article first published online: 11 DEC 2012
- Manuscript Received: 31 AUG 2012
Funded by
- National Institutes of Health. Grant Numbers: GM066137, GM079359, CA133086
- National Key Scientific Program of China. Grant Number: 2011CB911000
- China National Instrumentation Program. Grant Number: 2011YQ03012412
- Foundation for Innovative Research Groups of NSFC. Grant Number: 21221003
Keywords:
- aptamers;
- cell modification;
- cell recognition;
- cell-based immunotherapy;
- DNA
An apt modification: A simple and effective way to modify the cell surface with target-specific ligands, such as DNA aptamers, while minimizing the effects on the modified cells has been developed. After incubating with lipo–aptamer probes, immune cells (red, see scheme) recognize and kill cancer cells (blue) in the cell mixture.

1521-3773/asset/2002_left.gif?v=1&s=ac6b0d94a94d7ce7a210002b8096b42feffc0bcf)
1521-3773/asset/olbannercenter.gif?v=1&s=c083e1920cd41ed129901c116018eab93b5ad3c4)
1521-3773/asset/2002_right.gif?v=1&s=451042aa3415ae3ad0729984d26dee1866aca82e)
